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Background: Disturbances in the myocardial extracellular volume fraction (ECV), such as diffuse or focal myocardial
fibrosis or edema, are hallmarks of heart disease. Diffuse ECV changes are difficult to assess or quantify with
cardiovascular magnetic resonance (CMR) using conventional late gadolinium enhancement (LGE), or pre- or post-
contrast T1-mapping alone. ECV measurement circumvents factors that confound T1-weighted images or T1-maps,
and has been shown to correlate well with diffuse myocardial fibrosis. The goal of this study was to develop and
evaluate an automated method for producing a pixel-wise map of ECV that would be adequately robust for clinical
work flow.
Methods: ECV maps were automatically generated from T1-maps acquired pre- and post-contrast calibrated by
blood hematocrit. The algorithm incorporates correction of respiratory motion that occurs due to insufficient
breath-holding and due to misregistration between breath-holds, as well as automated identification of the blood
pool. Images were visually scored on a 5-point scale from non-diagnostic (1) to excellent (5).
Results: The quality score of ECV maps was 4.23 ± 0.83 (m± SD), scored for n = 600 maps from 338 patients with
83% either excellent or good. Co-registration of the pre-and post-contrast images improved the image quality for
ECV maps in 81% of the cases. ECV of normal myocardium was 25.4 ± 2.5% (m± SD) using motion correction and
co-registration values and was 31.5 ± 8.7% without motion correction and co-registration.
Conclusions: Fully automated motion correction and co-registration of breath-holds significantly improve the
quality of ECV maps, thus making the generation of ECV-maps feasible for clinical work flow.
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Cardiovascular magnetic resonance (CMR) using late
gadolinium enhancement (LGE) provides excellent de-
piction of myocardial infarction (MI) and focal scar, and
has become an accepted standard for assessing viability
[1]. LGE is also useful to detect and characterize fibrosis
that is “patchy” in appearance associated with non-
ischemic cardiomyopathies such hypertrophic cardiomy-
opathy (HCM) [2]. Diffuse myocardial fibrosis is more
difficult to distinguish using LGE since the myocardial
signal intensity may be nearly isointense and may be glo-
bally “nulled” thus appearing to be normal tissue [3].* Correspondence: kellmanp@nhlbi.nih.gov
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reproduction in any medium, provided the orQuantitative measurement of the myocardial tissue lon-
gitudinal relaxation time constant (T1) following admin-
istration of an extracellular Gadolinium-based contrast
agent is sensitive to increased extracellular volume asso-
ciated with diffuse myocardial fibrosis but has limitations
due to a variety of confounding factors [4,5] such as
gadolinium clearance rate, time of measurement, injected
dose, body composition, and hematocrit. These factors
cause a significant variation in post-contrast T1 making
it difficult to distinguish diseased and normal tissue
based on absolute T1 values. Pre-contrast T1 varies with
water content and may be elevated in cases of diffuse
myocardial fibrosis. Pre-contrast T1 also varies signifi-
cantly with field strength [6]. Direct measurement of
extracellular volume (ECV) was initially developed forl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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bution volume [7] and has been proposed as a means for
detection and quantification of diffuse myocardial fibro-
sis [3,8-13]. This approach is based on the change in T1
following administration of an extracellular contrast
agent and circumvents the limitation of a single post-
contrast T1 measurement in detecting a global change in
T1. The myocardial ECV is measured as the percent of
tissue comprised of extracellular space, which is a physio-
logically intuitive unit of measurement and is independ-
ent of field strength [6]. ECV has been shown to
correlate with collagen volume fraction [9,10]. This topic
is of current interest as a diagnostic tool for non-
ischemic cardiomyopathies as well as for understanding
aging processes [9,11-13]. The myocardial ECV may also
be elevated in edema [14] and may have benefits for
quantitative assessment as compared to simple T1 and
T2 measurements.
Current methods of generating ECV maps require
cumbersome off-line post processing [13]. The goal of
this study was to develop and evaluate an automated
method for producing a pixel-wise map of ECV that
would be adequately robust for clinical work flow. The
benefits of pixel-wise mapping over more commonly
used ROI based measurements is the ability to directly
visualize the spatial extent and severity of inhomogene-
ities in ECV in relation to anatomical boundaries. A
major challenge is the correction of motion that occurs
due to inconsistent breath-holding during the acquisi-
tion of images and due to patient movement between
breath-holds. The proposed method uses a new method
for motion correction of a series of inversion recovery
images with widely varying contrasts that is used for T1-
mapping [15], and incorporates a new scheme for co-
registration of pre-and post-contrast T1-maps.
Methods
ECV measurement
The ECV in the myocardium may be estimated from the
concentration of extracellular contrast agent in the myo-
cardium relative to the blood in a dynamic steady state
[7,9,13].









since the change in relaxation rate ΔR1 (where R1=1/
T1) between pre and post contrast is directly propor-
tional to the Gd-DTPA concentration, ΔR1= γ [Gd-
DTPA] (γ=4.5 L mmol-1 sec-1). A dynamic steady state
exists for tissues which have a contrast exchange rate
with the blood which is faster than the net clearance of
contrast from the blood [7]. A dynamic steady statebetween the plasma and interstitium may be achieved by
slow intravenous infusion [3,9], or by imaging 15 min
following an intravenous bolus administration [12,13] for
normally perfused myocardium, although 15 min may
not be adequate for recently infarcted myocardium [16].
The bolus method was used in this study since it fits well
with clinical workflow and permits conventional late en-
hancement imaging at the desired dose. The ECV for-
mula (Eq [1]) implies that our myocardial ECV
measurements include both the intra- and extravascular
space, and is related to the estimate of extracellular
extravascular volume fraction (Ve) [8,12] which includes
additional constant factors. The factor (1-hematocrit),
which varies between individuals, represents the blood
volume of distribution (blood ECV) and converts the
equation from a partition coefficient calculation to a
myocardial ECV.
Image acquisition
T1-mapping is based on inverting the magnetization and
acquiring images at different times during the
magnetization recovery. The acquisition is ECG triggered
and all images are acquired at the same cardiac phase in
late diastole using a Modified Look Locker Inversion Re-
covery (MOLLI) approach [17]. This method has been
validated [17,18]. Methods for T1-measurement such as
cine inversion recovery (IR) [8,19] which acquire the
measurements of magnetization at multiple cardiac
phases may be used for measuring the T1 in the myocar-
dium but are not suitable for mapping with pixel reso-
lution. Following respiratory motion correction
(described below), T1-fitting of the data at each pixel is
performed by a non-linear least square fit to the expo-
nential recovery curve abs(A – Bexp(−TI/T1*)), where
TI is the measured inversion time for each acquired
image, the absolute value (abs) is used since the images
are magnitude detected. T1* is the effective time con-
stant which includes the effect of the image readout [17]
related to the desired T1 as T1=T1* (B/A – 1). This
“Look-Locker” correction used in MOLLI [17] was
derived analytically [20] for the case of FLASH readout
with continuous RF, whereas in the case of MOLLI is
being applied to gated SSFP readout. This leads to bias
errors in T1 [21] which are reduced by using a relatively
low excitation flip angle. Imaging was performed on
1.5 T Siemens Avanto and Espree scanners (Siemens
Medical Solutions, Erlangen, Germany), equipped with
45 mT/m and 200 mT/m/s, and 33 mT/m and 170 mT/
m/s gradient systems, respectively. The study protocol
typically included acquiring T1-maps for 2 slices (mid-
ventricular short axis and four chamber long axis views)
both pre-contrast and approx. 15–20 min following
intravenous administration of 0.15 mmol/kg Gd-DTPA.
Both pre- and post-contrast T1-maps were acquired with
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MOLLI protocol [17] acquired 11 images over 17 heart-
beats. The MOLLI imaging protocol used in this study
acquired data at 8 inversion times over an 11 heart beat
breath-hold at end-expiration with 2 inversions. The ini-
tial protocol used acquired 3 images acquired after the
first inversion, 3 heart beat pause, and 5 images acquired
after the second inversion. The protocol was later modi-
fied to reduce heart rate variability by acquiring 5 images
after the first inversion, followed by a 3 heartbeat pause
and then acquire 3 images after the second inversion.
Both protocols (3–5 and 5–3) acquired 8 images in 11
heartbeats.
Typical imaging parameters were: non-selective inver-
sion pulse, steady state free precession single shot read
out with 35° excitation flip angle, field of view 360 ×
270 mm2, slice thickness 6 mm, minimum inversion time
110 ms, inversion time increment 80 ms, matrix
192×130, voxel size 2.1 × 1.9 × 6.0 mm3, TR/TE 2.4/
1.0 ms, 7/8 partial Fourier plus parallel imaging factor 2
with 140 ms readout imaging duration. The maximum
inversion time was approximately 5 sec at 60 bpm. The
protocol has subsequently been revised for increased
spatial resolution using a matrix of 256×144, TR/TE 2.7/
1.1 ms (200 ms readout imaging duration), with voxel
size 1.9 × 1.4 × 6.0 mm3 for heart rates < 90 bpm, and
192×130 for hearts above 90 bpm.
T1-Mapping and motion correction (MOCO)
Although patients are instructed to hold their breath
(typically 11 s) during the MOLLI acquisition of images
used for T1-mapping, residual respiratory motion fre-
quently introduces artifacts due to diaphragmatic drift or
difficulty with the breath-hold. If uncorrected, this mo-
tion may lead to errors in the pixel-wise estimation of
T1 thereby degrading the image quality of the T1-maps.
The unique challenge inherent to registration of inver-
sion recovery images acquired at different inversion
times is the large variation in image contrast (Figure 1).Figure 1 Pre- and post-contrast image series acquired using a Modifi
mapping.Furthermore, different tissue species with differing values
of T1 such as blood, fat, normal myocardium, edematous
myocardium, and infarcted myocardium will experience
signal nulling at different inversion times. Partial volume
cancellation at the boundaries between pixels of different
T1s will occur when the 2 species are out-of-phase
which further confounds the image registration problem.
The difference in contrast and appearance between
images is so large that simple pairwise image registration
using either intensity or mutual information based
metrics is inadequate.
In this study we used the novel motion correction al-
gorithm described by Xue, et al. [15] based on using
motion-free synthetic images presenting similar contrast
to the original acquired inversion recovery images. Add-
itionally, ECV maps were generated from motion cor-
rected T1-maps after co-registration and blood pool
measurements as described in following sections. Using
the synthetic image registration approach, the difficulty
of handling large variations of image contrast through-
out inversion recovery is bypassed. Motion correction is
done with an iterative approach based on initial T1 esti-
mates and the generation of a series of motion free syn-
thetic inversion recovery images which are used at each
inversion time for registration with the measured
MOLLI images. The initial T1-map is estimated using
images acquired at the shortest and longest values of TI,
which results in a crude estimate of T1 sufficient to
initialize the iterative process. It was determined that al-
though the contrast between the short and long TI
images is not identical, these images were suitable for
registration since they avoided the problem of tissue nul-
ling and partial volume cancellation. From the initial es-
timate of T1 at each pixel, synthetic images are
calculated exploiting the known exponential form of in-
version recovery. Synthetic images are calculated for
each of the measured images using the estimated values
of T1. The synthetic images are all at a fixed respiratory
position and, importantly, each synthetic image hased Look Locker Inversion Recovery (MOLLI) sequence used for T1-
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making them suitable for intensity based image registra-
tion. Due to the non-rigid nature of tissue deformation
caused by respiratory motion, a non-rigid image registra-
tion algorithm based on the classical optical flow method
was to estimate the motion deformation [15]. Image warp-
ing for both MOCO and co-registration utilized a
5th-order B-spline interpolator in order to minimize loss
of spatial resolution.
Following motion correction, the T1 map is generated
by a pixel-wise curve fitting using a three parameter sig-
nal model for MOLLI inversion recovery. The downhill
simplex minimization algorithm was used [15]. At each
pixel the sum-of-squares of the residual errors of the
measured data to the exponential model fit was calcu-
lated as a goodness of fit map.
Co-registration
Pre- and post-contrast image series are acquired in separ-
ate breath-holds which are typically 15–30 minutes apart.
Even small differences in respiratory position or changes
in patient position due to movement will cause significant
misregistration of the images. Co-registration of the pre-
and post-contrast images is performed (Figure 2) using aFigure 2 Schematic flow chart for automatic generation of ECV maps
inversion recovery image series, co-registration of each series with ea
different for pre and post contrast examples.non-rigid image registration applied to the longest inver-
sion time image of the already motion corrected images.
In this way, the magnetization of the long inversion time
images is almost completely recovered and the image
contrast between pre- and post-contrast series will be
very similar thereby facilitating intensity based image
registration methods. Co-registration is achieved by ap-
plying the estimated motion deformation field to the
post-contrast series. Rather than simply applying the de-
formation (warping) to the T1-map or to the already mo-
tion corrected image series, a composite deformation
using the original respiratory motion fields of the post-
contrast series combined with the deformation from the
co-registration step is applied a single time to avoid an
unnecessary loss of spatial resolution. The final T1-map
for the post-contrast series is calculated by pixel-wise
fitting.
The complete processing workflow was fully automated.
Once the user specifies the study, the software retrieves all
images for appropriate paired series of pre andpost contrast
MOLLI acquisitions at the same slice location, performs all
processing, andproducesT1-maps andECVmaps indicom
format which may be pushed to the PACS. The processing
time in the current implementation is approximately 45 secby respiratory motion correction of pre- and post-contrast
ch other, and blood pool segmentation. Note that color scales are
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mapping with MOCO and co-registration, and blood
pool segmentation.
Blood pool segmentation
Calculation of the ECV (Eq [1]) requires knowledge of
the change in blood relaxation rate (ΔR1blood). An auto-
matic method determining a blood region was developed
based on the pre-contrast T1-map. The pre-contrast T1
of blood is in the range 1300–1800 ms which is greater
than the T1 of most tissues. A binary mask was created
from the pre-contrast T1 map using a threshold of
1250 ms. Isolated pixels which might be attributed to
noise were removed, and the resultant mask was
“eroded” to remove edge pixels that might correspond to
blood-tissue boundaries with intermediate values due to
partial volume effects (Figure 3). The values for pre- and
post-contrast blood T1 were calculated as the median of
all values of the T1-map identified by the mask. The
post-contrast T1-map was, as a result of the co-registra-
tion, located in the same position as the pre-contrast T1-
map. The change in blood relaxation rate was subse-
quently calculated as ΔR1blood = 1/T1post – 1/T1pre.
Automatic calculation of blood T1’s were compared with
values from manually drawn ROIs in N=50 subjects.
Scoring
ECV maps were scored for overall quality based on a 5
point scale. N= 600 maps corresponding to 338 patients
imaged consecutively were scored. The rating was based
on image artifacts, delineation of myocardial blood pool
borders, and homogeneity of myocardial signal. A score
of 5 (excellent) was assigned when the myocardial bor-
ders were crisp and distinct from the blood pool with less
than or equal to 1 pixel of partial volume border and no
noticeable geometric distortion. The myocardial signalFigure 3 Example T1-maps acquired pre- (left) and post- (center) con
T1-values of blood for ECV calculation. Manually drawn blood pool ROIshad to be homogeneous (uniform ECV) in areas assessed
to be normal tissue (i.e., no focal scar on late enhance-
ment). A score of 4 (good) was assigned when one of the
above criteria was absent, i.e., there were 1–2 pixels of
representative myocardial ECV with slightly increased
border between blood and myocardium, or geometric dis-
tortion were present but not impacting the ECV values,
or there were small regions (10%) of inhomogeneity in
the myocardium. A score of 3 (fair) meant that that 2 cri-
teria under the excellent category were absent, i.e., only a
thin stripe of myocardium was present from which to
sample the representative ECV, or geometric distortion
was present, or multiple regions had inhomogeneity
deemed to be artifactual but affected less than 50% of the
myocardium. A score of 2 (poor) meant that inhomo-
geneities or geometric distortion affected greater than
50% of the myocardium making it difficult to distinguish
regions of normal myocardium from noise or artifacts,
but that ECV sampling was still possible in isolated areas.
A score on 1 (non-diagnostic) meant that ECV could not
be measured reliably anywhere in the myocardium.
Examples of ECV maps in each scoring categories are
shown in Figure 4(a). It is important to note that in for
certain pathologies, the partial volume at the blood myo-
cardium border may be mistaken for pathology or vice-
versa, as emphasized in the Discussion. For the purpose
of the scoring the quality of maps, the readout involved a
judgment based on comparison of all the maps including
with and without motion correction and/or co-registra-
tion, as well as LGE images and patient history.
Performance of the motion correction and co-
registration of T1-maps were scored separately in addition
to the overall ECV map quality. These sub-scores were
assessed as follows. Pre-contrast T1-maps were compared
before and after MOCO, and were assessed as to whether
the MOCO T1-map was better, the same, or worse thantrast and automatic segmentation mask (right) used to estimate
were used for comparison with automatic segmentation estimates.
Figure 4 Quality of ECV maps was scored on a scale of 1–5 for N= 600 maps across 338 subjects. ECV map images are provided as
examples for each quality category.
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and without MOCO were similarly scored. The basis of as-
sessment was the improvement of myocardial borders and
reduction of artifacts. Performance of the co-registration of
pre- and post-contrast data was similarly scored according
to better, same, or worse by comparing the ECV maps but
with and without the step of co-registration.
Human subject protocol
ECV imaging was performed between Sept 2009 and
May 2011, 952 patients referred for CMR assessment of
known or suspected heart disease prospectively under-
went ECV imaging. Hematocrit was measured from a
venous blood sample drawn just prior to the CMR study.
This study was approved by the local Institutional Review
Boards of the National Heart, Lung, and Blood Institute
and Suburban Hospital, and all subjects gave written
informed consent to participate. A total of 1680 ECV
maps were generated by automated off-line processing as
described above (728 studies imaged matching short and
long axis views both pre- and post-contrast, and the 224
remaining studies only acquired a single slice). Scoring of
ECV map quality was performed on 600 maps (338 sub-
jects) acquired consecutively, and statistics for automatic
blood measurements were made based on the complete
set. Additionally, cine MRI of cardiac function and phase
sensitive inversion recovery (PSIR) late Gadolinium en-
hancement imaging [22] was performed on all subjects.ECV measurement
For the purpose of establishing the value of ECV in
“normal” myocardium, subjects were categorized as
“normal” if they were without known significant sys-
temic illness, demonstrated normal biventricular systolic
function, chamber size, and wall thickness, absent sig-
nificant valvular dysfunction, were assessed clinically as
LGE negative and did not have apparent edema as evi-
denced by elevated pre-contrast T1 [23]. Subjects with
diabetes or hypertension were excluded. In order to es-
tablish ECV values for normal myocardium, ROIs for
normal subjects were drawn in a mid-wall region of the
myocardium to avoid contamination from partial vol-
ume with the blood pool. Values were measured on
ECV maps with and without motion correction/co-
registration.
Statistics
Data are presented as mean and standard deviation. Dif-
ferences between groups were tested by the paired or
unpaired t-test as appropriate. Differences in variance
were tested by the F test. Statistical significance was
defined as p < 0.05.
Results
Blood measurements
The measured hematocrit was 41.2 ± 4.8% (N = 952
subjects) and ranged from a minimum of 18% to a
Figure 5 Performance of motion correction of T1-maps and co-registration for ECV-maps was scored as to whether or not there was
visually detectable improvement or degradation.
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tween the estimates of blood pool T1 made by the
automatic blood pool segmentation and manually
drawn ROIs (Figure 3) for N = 50 subjects. The correl-
ation between T1-estimates using manual vs auto-
matic blood pool segmentation was r = 0.95 (P < 0.001)
for pre-contrast and r = 0.99 (P < 0.001) for post-
contrast acquisitions. The pre-contrast T1 was
1473.2 ± 61.8 ms and 1478.1 ± 64.7 ms (p = 0.07), using
automatic and manual measurement respectively. The
post-contrast T1 was 321.9 ± 43.5 ms andFigure 6 Example case of post-contrast T1-maps acquired with signif
MOCO, particularly in the septal region (arrows). Residual errors from e
inversion time for a pixel at the edge of the septum (left) and a pixel at th320.9 ± 42.6 ms (p=0.10), using automatic and manual
measurement respectively.
Quality scores
The quality of ECV maps was 4.23 ± 0.83 based on
N=600 maps corresponding to 338 unique, consecutive
subjects. This corresponded to 271 excellent, 225 good,
87 fair, 12 poor, and 5 non-diagnostic (Figure 4(b)). T1
maps with motion correction were assessed to be better
(14%), the same (85%), and worse (<1%) for pre-contrast
image series as compared to without correction, andicant respiratory motion which is significantly improved by
xponential model fit (arbitrary signal intensity units) are plotted versus
e center of the septum (right) before (non-MOCO) and after MOCO.
Figure 7 Example case for which co-registration of data between pre- and post-contrast T1-maps acquisitions was critical. In these
examples, MOCO co-registration of the respective maps markedly improved the ECV map, eliminating an artifactually high ECV in the inferior
septum (arrows) in the non-co-registered maps. MOCO did not improve the quality of individual (pre- and post-contrast) T1-maps for this
example, however MOCO+ co-registration was significantly improved.
Table 1 Patient characteristics and risk factors for the 62
subjects used to define normal values
Age 43.6 ± 17.4
Gender 30 male, 32 female
Family History of CAD 10




BMI (kg/m2) 26.5 ± 4.6
Creatinine (mg/dL) 0.88 ± 0.19
LVEF (%) 61.7 ± 5.9
LVEDV (mL) 143.9 ± 32.9
LVEDV index (mL/m2) 76.8 ± 12.2
LV mass (g) 87.4 ± 26.2
LV mass index (g/m2) 46 .2 ± 9.5
Wall Thickness (mm) 7.5 ± 1.8
BMI=Body Mass Index, LV= left ventricular, EF= ejection fraction, EDV= end-
diastolic volume. Wall thickness was measured in the basal anteroseptum.
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(<1%) for post-contrast (Figure 5). A small number of
instances arose in which the MOCO resulted in signifi-
cant geometric distortion leading to mis-registration
which worsened the overall score. An example of a case
where MOCO improved the T1-map is shown in Figure 6
comparing the non-corrected (left) and corrected (right)
map, and corresponding maps of T1-fitting error. The
T1-fitting error is plotted versus the inversion time for a
representative edge pixel and a midmural pixel to further
illustrate the improvement after motion correction. Co-
registration of the pre-and post-contrast images
improved the ECV maps in 81% of the cases (example
shown in Figure 7), were the same in 17%, and were
worse in 2% of the cases.
ECV measurements
Patient characteristics and risk factors for the 62 subjects
used to define the range of normal values are listed in
Table 1. ECV of normal myocardium was 25.4 ± 2.5%
using motion correction and co-registration measured in
the mid-wall for 62 subjects which were LGE negative
Figure 8 Measured ECV values (n = 62 subjects) for normal
myocardium measured in the mid-wall of the myocardium with
and without motion correction and co-registration showing
that motion correction significantly reduces variability
(p < 0.001). Box and whisker plots show median, 25 and 75
percentiles, and range.
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tion or co-registration the apparent ECV values were
30.8 ± 7.8% (P < 0.001 compared to motion correction
and co-registered). The ECV measurements without mo-
tion correction and co-registration had a greater vari-
ation due to contamination with blood or other tissue
(7.8% vs 2.5%, P < 0.001, Figure 8). The ECV of normal
myocardium with motion correction had a normal range
(mean ± 2SD) which was 20.4-30.4%.
Discussion
Benefits of pixel-wise ECV mapping
ECV mapping appears promising to complement LGE
imaging in cases of more homogenously diffuse myocar-
dial disease states which affect the myocardial extracellu-
lar space. The ability to display ECV maps in
quantitative units that may be interpreted on an absolute
scale offers the potential for simplified detection and
measurement of the extent of abnormalities affecting the
myocardial ECV. There is a continuous spectrum of
spatial heterogeneity between diffuse and focal fibrosis.
The use of pixel-wise mapping offers a new tool to better
assess the heterogeneity of the myocardial tissue and to
measure ECV of the diseased regions.
Limitations
The ability to distinguish partial volume border pixels and
correctly determine whether pixels are contaminated by
partial volume effects, or are true pathophysiology such as
subendocardial or subepicardial fibrosis, is a residual and
important issue. This issue is not only important in terms
of the visual readout, but may introduce biases into quan-
titative measurements which become particularly signifi-
cant in the context of more subtle diseases. One approach
to reducing the bias in measurements is to restrict the
measurement to the mid-wall region, although one mustexercise caution for subjects with thin walled myocardium
or patients with thin rims of subendocardial fibrosis.
The proposed approach to generating ECV maps
resulted in excellent to good image quality maps in 83% of
the cases. A number of factors contributed to cases of
poor quality images. In some cases patient movement
resulted in the slices being substantially different in ap-
pearance despite the fact that the same slice position was
prescribed. Co-registration is by design only capable of
correcting for in-plane motion and cannot compensate for
through plane motion, although it may appear to partially
compensate. In other cases, it is clear that the pre- and
post-contrast images are at substantially different cardiac
phases due to significant change in heart rate, despite
adjusting the trigger window. Both of these factors might
be improved at the time of acquisition by more careful in-
spection but this would complicate the workflow.
The interpretation probably can be improved by exam-
ining the pre-and post-contrast T1-maps for consistent
appearance of position and cardiac phase as a quality
control step. Furthermore, it is expected that the use of
ECV maps will be in conjunction with pre-contrast T1-
maps and conventional late enhancement images, and
not read independently. As such, the ability to assess and
quantify diffuse fibrosis in ECV images should provide
increased diagnostic confidence since LGE image quality
is generally excellent and will not share the same arti-
facts. Finally, the use of residual error maps (Figure 7)
offers a potential as another quality metric to increase
the confidence for a given region. In other words, if the
error map indicates that the motion correction is high
quality (low error), then the ECV values are more
accurate.
Partial volume effects affect the measurement of ECV.
Partial volume effects are a result of limits in in-plane
spatial resolution as well as slice thickness and are
observed at tissue borders such as for pixels between
blood and myocardial tissue. Partial volume effects also
affect the measurement of fine structures such as MI
contributing to a larger variability. These same factors
are also a limitation in LGE. These effects are less of a
factor for measurements of globally diffuse disease.
The issue of achieving a “dynamic steady state” using a
bolus [12,13] rather than slow infusion [3,9] has been
studied by several researchers, however, the accuracy of
this assumption and the corresponding impact on quan-
titative ECV measurements is unknown. In particular, it
has been noted that steady state may take longer to
achieve in acute myocardial infarction [16], therefore fur-
ther work is required to investigate this limitation.
Despite these issues, ECV maps may be readily incor-
porated into the clinical workflow and may provide diag-
nostic information where other methods are limited. It is
not intended to replace existing methods such as LGE
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to be used in concert with other techniques. When ECV
is abnormally elevated, it may not be clear whether this is
due to fibrosis or edema which may be either diffuse or
focal. In such instances, pre-contrast T1 or T2 maps, in
addition to patient history and contextual imaging clues
like signs of heart failure, may help to differentiate these
mechanisms.
The presence of intra-myocardial fat may affect the
estimates for ECV and has not been studied. In cases of
fat with low fat fraction, voxels with partial volume of fat
and myocardial tissue may lead to errors in T1-mapping
which assume a mono-exponential model for single T1-
species. Furthermore, fat is not in fast chemical exchange
with the Gadolinium contrast agent and will not experi-
ence the same T1 shortening. Multi-echo fat water sepa-
rated inversion recovery may be used for late
enhancement [24,25] but is challenging to incorporate
into a T1-mapping sequences. Fat water separated im-
aging may also be used in the combined assessment to
identify the presence of intra-myocardial fat.
In this study, the generation of ECV maps was per-
formed off-line and retrospectively. In order to wholly
automate the generation of ECV images on the scanner
at the time of imaging, hematocrit would either have to
be entered manually or automatically queried from a
clinical database. These options are potentials for im-
provement which remain to be explored in order to
make the generation of ECV images wholly automatic on
the scanner as a part of the clinical work flow. While it
is possible to compute a partition coefficient map with-
out using the value of hematocrit [26], the variability in
hematocrit (18.3% to 65% in this series) makes the parti-
tion coefficient less useful for measuring subtle changes
in ECV expected for diffuse fibrosis.
The method for automatic segmentation of the blood
pool was effective for mid-ventricular short axis or long
axis views acquired in this study. For volumetric cover-
age which would include apical slices with a reduced size
of the region of blood, it might be necessary to adapt this
method to use blood values acquired at other slices with
the proviso that they must be acquired in close time
proximity such that the blood T1 remains the same.
T1-mapping accuracy and precision
The accuracy and precision of T1-mapping using the
MOLLI method is affected by a number of factors includ-
ing the protocol, the sequence design, patient specific fac-
tors related to heart rate and blood flow, and system
adjustments such as center frequency and shim. The
MOLLI method for T1-mapping is widely use and a num-
ber of adaptions to the protocol have been introduced to
shorten the acquisition time. Further optimization the se-
quence and of pre- and post-contrast T1-mappingprotocols based on the MOLLI strategy is the subject of
ongoing research.
A shortened acquisition acquiring 7 images in 9 heart-
beats (known as ShMOLLI) [27] may be used to further
reduce the breath-hold duration and achieve a heart rate
independent T1 measurement by discarding samples for
tissue with longer T1. The 11 heart beat protocol used in
this study achieves a reliable T1 measurement by using a
longer recovery between inversions without eliminating
data. At longer T1’s the 9 heart beat ShMOLLI protocol
uses only 5 images for T1-fitting, whereas the proposed
motion corrected 11 heart beat protocol uses all 8
acquired images. The increased number of images
reduces the fitting error.
In terms of the sequence design, we have recently
determined that imperfect inversion efficiency leads to
an underestimation of T1, representing the largest
source of systematic error. This error may be greatly
reduced by means of an improved inversion pulse design
as well as by applying an appropriate correction. These
corrections were not available at the time of this study.
As a result, the normal values for T1 are underestimated
by as much as 5-10%. However the systematic bias in
T1-measurement results in only a small overestimation
of ECV, estimated on the order of 1% or less in ECV
units. This does not alter the main conclusions of this
present study on the utility of ECV maps.
Conclusions
While LGE is an excellent method for detection of focal
scarring as encountered in myocardial infarction and nu-
merous other cardiomyopathies, ECV mapping appears
promising to augment LGE imaging in cases of more
homogenously diffuse disease. The fully automated im-
plementation lends itself to incorporation of ECV map-
ping directly into a clinical workflow. Motion correction
and co-registration of breath-holds have been demon-
strated to significantly improve the image quality of ECV
maps.
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